/ /

Laird Harrison
Cannabis remains problematic for glaucoma
Cannabis remains problematic for glaucoma
Despite the legalization of marijuana by several state governments, physicians should not recommend smoking it as a treatment for glaucoma, said Sunita Radhakrishnan, MD. “It has been approved by public opinion rather than regulatory process,” she said.
Argon laser iridoplasty effective in occludable eyes treated with iridotomy
Argon laser peripheral iridoplasty (ALPI) significantly widens the anterior chamber angle circumferentially in eyes with occludable angles treated with laser peripheral iridotomy, researchers say.
‘Real-world’ ocriplasmin macular hole closure rates lag trials
Ocriplasmin (Jetrea, ThromboGenics) may achieve lower macular hole closure rates than in trials, new British and Irish data suggests. Also, “the incidence of adverse events was greater than previously reported,” wrote RJ Haynes of Bristol Eye Hospital in Bristol, United Kingdom, and colleagues in the journal Eye.
Computer-based image analysis promising for ROP
Computers may make more reliable diagnoses of plus disease in retinopathy of prematurity than individual clinicians, a researcher reports.
Roles of Klotho and Endothelin-1 in pseudoexfoliation
Serum and aqueous levels of Klotho levels are reduced in pseudoexfoliation syndrome (PXF) and pseudoexfoliative glaucoma (PEG) while Endothelin-1 (ET-1) is increased, researchers say.
Why UK patients travel abroad for laser eye surgery
More citizens from the United Kingdom are traveling abroad for laser eye procedures, according to a medical travel website. Enquiries from the United Kingdom into overseas clinics for laser procedures rose 60% in the 12 months ending November 15, 2016, according to WhatClinic.com, which lists medical clinic by location.
How glucosamine supplements may increase IOP
The finding raises questions about whether the supplements could play a role in glaucoma, wrote H. Esfandiari of the University of Medical Sciences in Tehran, Iran and colleagues in the journal Eye.
Pain-preventing NSAID welcomed by patients and clinicians
A new 0.075% formulation of bromfenac ophthalmic solution (BromSite, Sun Pharma) could provide relief from pain and inflammation associated with cataract surgery.


View Results